GlobeNewsWire
01 Nov 2026, 19:59 UTC · 2h ago
Impact · against what's priced in
Anteris (AVR) shows positive early hemodynamic and safety results for its Medium-size DurAVR valve, specifically highlighting 100% freedom from moderate/severe PPM. This reduces technical risk for future pivotal trials, providing a modest positive catalyst for the stock.
No priced-in read yet
What the story claims
3 claims · scored −1 bearish … +1 bullish · 3 new · 0 priced in
The Medium-size DurAVR THV showed 100% freedom from moderate or severe prosthesis-patient mismatch (PPM) in 22 severe aortic stenosis patients.
Newannounced today, Nov 01, 2026
So whatSuccess in this specific annulus size (492 ± 38 mm2) reduces the risk of failure in subsequent larger pivotal trials.
More positive than 92% of claims this week
Continue reading
5 related stories
The 30-day outcomes for the Medium-size DurAVR THV, including single digit mean gradients and zero valve-related mortality in 22 patients, provide concrete evidence of device performance and reduce the risk of failure in larger trials.
Read from the article alone
Scored by the NIS engine · methodology.
The DurAVR THV demonstrated no valve-related mortality and no moderate or severe paravalvular leaks at 30 days.
Newannounced today, Nov 01, 2026
More positive than 85% of claims this week
Clinical outcomes for the device showed single digit mean gradients and large effective orifice areas (EOAs).
Newannounced today, Nov 01, 2026
More positive than 76% of claims this week
Which stocks this story touches
More positive than 87% of ticker scores this week
The company announced positive clinical and hemodynamic outcomes for its DurAVR Transcatheter Heart Valve.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
The Motley Fool
2h ago
—
AVR hasn't traded since this ran. Last close $6.31 (Oct 30); the reaction starts at the next open.
AVR chart →
